Ireland· IE-PA-PA1122/043/001
Aciclovir 250 mg powder for solution for infusion
A aciclovir product containing aciclovir, registered in Ireland by Noridem Enterprises Limited. The same ATC class is registered in 17 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Aciclovir is registered in 17 of 19 countries.
Countries holding a registration under ATC J05AB01 (aciclovir), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 10 of them publish a price we can compare per daily dose
Aciclovir · ATC J05AB01
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of aciclovir costs, country by country.
Normalised to the WHO defined daily dose (4 g), the median price runs from $4.07 in Italy to $13.83 in Switzerland — a ×3.4 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Aciclovir · price per daily dose (4 g)
USD · FX 28 Sept 2026
- CH Switzerland$13.83
- IT Italy$4.07
The record
At a glance
HPRA (Ireland)- Active substance
- Aciclovir
- Manufacturer
- Noridem Enterprises Limited
- Country
- Ireland (IE)
- ATC code
- J05AB01
- ATC class
- Aciclovir
- Defined daily dose
- 4 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1122/043/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
560 interactions on record for aciclovir.
Graded by severity as the source publishes them — 19 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aciclovir · interactions on record
560 records
- 19 severe
- 27 moderate
- 7 minor
- 505 info
Most severe, free to view
- CidofovirJ05AB12severe
- TemsirolimusL01EG01severe
- EverolimusL01EG02severe
- SirolimusL01EG04severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Aciclovir in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAciclovir 250mg powder for solution for infusion vialsWockhardt UK Ltd
- SpainACICLOVIR ACCORD 250 MG POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN EFGAccord Healthcare S.L.U.
- CzechiaACICLOVIR NORIDEMNoridem Enterprises Limited, Nikosia
- PolandAciclovir AltanAltan Pharmaceuticals, S.A.
- BelgiumAciclovir Hikma 250 mgHikma Farmacêutica
- FinlandAciclovir NoridemNoridem Enterprises Limited
- SwedenAciclovir Noridem 250 mg Pulver till infusionsvätska, lösningNoridem Enterprises Ltd
- United StatesacyclovirNorthwind Health Company, LLC
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Aciclobene, Aciclostad
- Belgium · Aciclovir Ab, Aciclovir Agepha
- Bulgaria · Ацик, Ацикловир Абр
- Cyprus · Aciclovir Accord, Aciclovir Noridem
- Czechia · Aciclovir Accord, Aciclovir Noridem
- Germany · Acic, Acic Creme Bei Lippenherpes
- Denmark · Aciclodan, Aciclovir 1a Farma
- Estonia · Acic, Aciclovir Accord
- Spain · Aciclovir Accord, Aciclovir Altan
- Finland · Aciclovir Accord, Aciclovir Noridem
- France · Aciclovir Accord, Aciclovir Agepha
- United Kingdom (Northern Ireland) · Aciclovir, Aciclovir Accord Healthcare
- Greece · Aciclovir Vocate, Cevinolon
- Croatia · Aciklovir Accord, Aciklovir Alpha-Medical
- Hungary · Aciclovir Agepha, Aciclovir Al
- Iceland · Aciclovir Accord, Aciclovir Alvogen
- Italy · Aciclin, Aciclinlabiale
- Lithuania · Acic, Aciclovir Accord
- Luxembourg · Aciclovir, Aciclovir Eg
- Latvia · Acic, Aciclovir Accord Healthcare
- Malta · Medovir, Uniplex
- Netherlands · Aciclovir Accord, Aciclovir Agepha
- Norway · Aciclovir Accord, Aciclovir Noridem
- Poland · Aciclovir Accord, Aciclovir Altan
- Portugal · Aciclosina, Aciclovax - Iv
- Romania · Acevirex, Aciclovir
- Sweden · Aciclovir Accord, Aciclovir Noridem
- Slovenia · Aciclovir Noridem, Aciklovir Accord
- Slovakia · Aciclovir Noridem, Aciclovir Olikla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/75dea5ef-343e-4ddb-bb85-31bd7812c74d GET /v1/drugs/75dea5ef-343e-4ddb-bb85-31bd7812c74d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"J05AB01"
],
"strength": null,
"pa_number": "PA1122/043/001",
"substances": [
"Aciclovir"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "24/01/2025",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about aciclovir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.